Federal grants to Xlock Biosciences, Inc.
Xlock Biosciences, Inc. in Muskego, Wisconsin received $2.7 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Arthritis, Musculoskeletal and Skin Diseases Research, with $2.5 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.7 million
- Awards3
- Awarded in FY 2025$0
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $829,097 |
| FY 2022 | 1 | $259,613 |
| FY 2023 | 1 | $998,606 |
| FY 2024 | 1 | $624,864 |
| FY 2025 | 0 | $0 |
Programs that fund Xlock Biosciences, Inc.
| Program | Awards | Amount |
|---|---|---|
| Arthritis, Musculoskeletal and Skin Diseases Research | 2 | $2.5 million |
| Cardiovascular Diseases Research | 1 | $253,748 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.7 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Targeting the CCR6-CCL20 pathway for treatment of psoriatic joint and entheseal inflammation - project summary/abstract the goal of this project is to develop and validate a novel therapeutic lead compound for the treatment of psoriatic arthritis (PSA). Chemokines orchestrate the migration of inflam | Arthritis, Musculoskeletal and Skin Diseases Research | August 8, 2023 | $2.0 million |
| Development of an engineered CCL20 protein as a lead therapeutic molecule for psoriasis | Arthritis, Musculoskeletal and Skin Diseases Research | March 1, 2021 | $493,625 |
| Development of an engineered CCL20 as a therapeutic molecule for chronic graft-versus-host disease - project summary/abstract the goal of this project is to validate a novel therapeutic lead compound for the treatment of chronic graft versus host disease (CGVHD). Chronic graft versus host disease (c | Cardiovascular Diseases Research | June 9, 2022 | $253,748 |
Questions people ask
How much federal grant money does Xlock Biosciences, Inc. get?
$2.7 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Xlock Biosciences, Inc. the most?
The Department of Health and Human Services, with $2.7 million in 3 awards.
What is Xlock Biosciences, Inc.'s largest federal grant?
$2.0 million under Arthritis, Musculoskeletal and Skin Diseases Research, with its first action in the period on August 8, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Xlock Biosciences, Inc.?
Its largest are Arthritis, Musculoskeletal and Skin Diseases Research and Cardiovascular Diseases Research.
Largest federal grant recipients in Wisconsin · Federal grants in Wisconsin